Market Research Report - 242925
Oral Transmucosal Drug Delivery to 2018: Products, Players, Markets & Forecasts
|Published by||Greystone Research Associates|
|Oral Transmucosal Drug Delivery to 2018: Products, Players, Markets & Forecasts|
|Published: May 1, 2014||Content info:||
In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. Growth in this sector will be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.